Evidence map›Paper›PMID 27586202›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2016

Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.

Michelle D Reid, Serdar Balci, Nobuyuki Ohike, Yue Xue, Grace E Kim, Takuma Tajiri, Bahar Memis, Ipek Coban, Anil Dolgun, Alyssa M Krasinskas and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Rare, Yet Targetable: New Perspectives on Ampullary Carcinomas.International journal of molecular sciences · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Michelle D ReidDepartment of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Serdar BalciDepartment of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Nobuyuki OhikeDepartment of Pathology, Showa University Fujigaoka Hospital, Yokohama, Japan.
Yue XueDepartment of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Grace E KimDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USA.
Takuma TajiriDepartment of Pathology, Tokai University Hachioji Hospital, Tokyo, Japan.
Bahar MemisDepartment of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Ipek CobanDepartment of Pathology, Istanbul Bilim University, Florence Nightingale Hospital, Istanbul, Turkey.
Anil DolgunDepartment of Biostatistics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Alyssa M KrasinskasDepartment of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Olca BasturkDepartment of Pathology, Wayne State University, Detroit, MI, USA.
David A KoobyDepartment of Surgery, Emory University School of Medicine, Atlanta, GA, USA.
Juan M SarmientoDepartment of Surgery, Emory University School of Medicine, Atlanta, GA, USA.
Shishir K MaithelDepartment of Surgery, Emory University School of Medicine, Atlanta, GA, USA.
Bassel F El-RayesDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
Volkan AdsayDepartment of Pathology, Emory University School of Medicine, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histologic classification of ampullary carcinomas as intestinal versus pancreatobiliary is rapidly becoming a part of management algorithms, with immunohistochemical classification schemes also being devised using this classification scheme as their basis. However, data on the reproducibility and prognostic relevance of this classification system are limited. In this study, five observers independently evaluated 232 resected ampullary carcinomas with invasive component >3 mm. Overall interobserver agreement was 'fair' (κ 0.39; P<0.001) with complete agreement in 23%. Using agreement by 3/5 observers as 'consensus' 40% of cases were classified as 'mixed' pancreatobiliary and intestinal. When observers were asked to provide a final diagnosis based on the predominant pattern in cases initially classified as mixed, there was 'moderate' agreement (κ 0.44; P<0.0001) with 5/5 agreeing in 35%. Cases classified as pancreatobiliary by consensus (including those with pure-pancreatobiliary or mixed-predominantly pancreatobiliary features) had shorter overall (median 41 months) and 5-year survival (38%) than those classified as pure-intestinal/mixed-predominantly intestinal (80 months and 57%, respectively; P=0.026); however, on multivariate analysis this was not independent of established prognostic parameters. Interestingly, when compared with 476 cases of pancreatic ductal adenocarcinomas, the pancreatobiliary-type ampullary carcinomas had better survival (16 versus 41 months, P<0.001), even when matched by size and node status. In conclusion, presumably because of the various cell types comprising the region, ampullary carcinomas frequently show mixed phenotypes and intratumoral heterogeneity, which should be considered when devising management protocols. Caution is especially warranted when applying this histologic classification to biopsies and tissue microarrays. While ampullary carcinomas with more pancreatobiliary morphology have a worse prognosis than intestinal ones this does not appear to be an independent prognostic factor. However, pancreatobiliary-type ampullary carcinomas have a much better prognosis than their pancreatic counterparts.

Indexed as

AdultAgedAged, 80 and overAmpulla of VaterBiomarkers, TumorCarcinoma, Pancreatic DuctalCommon Bile Duct NeoplasmsDuodenal NeoplasmsFemaleHumansKaplan-Meier EstimateMaleMiddle AgedProportional Hazards ModelsBiomarkers, Tumor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.